| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.13 | 0.006 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.44 | 0.008 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.01 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.01 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.02 |